Key Findings

The study identifies a novel SHV-type beta-lactamase, SHV-104, with a single point mutation (R202S) and characterizes its enzymatic properties. Additionally, the plasmid-borne CTX-M-28 beta-lactamase was identified as a significant contributor to the multidrug-resistant phenotype of the isolate.